Kodiak Sciences KOD 深 沪
等待开盘 09-30 09:30:00 美东时间
91.12
+1.200
+1.33%
华盛通- 最 高93.1386
- 今 开87.20
- 成交量 602.70万股
- 最 低 83.6401
- 昨 收 89.92
- 总市值 57.27亿
- 52周最高 95.77
- 市盈率 静 --
- 换手率 9.59%
- 52周最低 10.94
- 委 比 88.68%
- 总股本 6284.95万
- 历史最高 171.21
- 量 比 0.68
- 振 幅 10.56%
- 历史最低 1.37
- 每 手 1
- 风险率 9.91%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股牛股 | Kodiak暴升178%！wAMD三期临床试验大获成功；黑莓升逾7%，Q2营收超预期，QNX业务表现强劲
Kodiak暴升178%！wAMD三期临床试验大获成功；AMC升近12%，39.7亿美元债务再融资；黑莓升逾7%，Q2营收超预期，QNX业务表现强劲>>
09-29 17:03
美股大行评级 | 潜在涨幅919.61%！HC Wainwright上调NeuroSense Therapeutics目标价至52美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持NeuroSense Therapeutics"买入"评级，目标价从8美元升至52美元；HC Wainwright & Co.：维持艾切托"买入"评级，目标价从27美元升至34美元
09-29 08:33
Regeneron Eylea Feels the Pinch as Kodiak Advances Extended Dosing for Eye Drug
Regeneron Pharmaceuticals Inc.’s (NASDAQ:REGN) stock is trading lower on Monday, probably in reaction to positive data from Kodiak Sciences Inc.’s (NASDAQ:KOD) data from the Phase 3 DAYBREAK trial for wet age-related macular degeneration (wAMD). The study demonstrated that Zenkuda and tabirafusp-ted...
09-28 23:17
Kodiak Sciences posts positive Phase 3 DAYBREAK eye results
Kodiak Sciences ( ($KOD) ) has provided an update. On September 28, 2026, Kodia...
09-28 21:25
Biggest stock movers Monday: GFI, NIO, and more
Stock futures were lower Monday morning as Washington rejected Iran's truce offer, sending Brent crude above $107 and Treasury yields toward 5% alongside deepening tech and AI safety concerns. Here ar...
09-28 17:01
美股大行评级 | Meta获4家机构齐升目标价，最高看至995美元！麦当劳遭6家机构下调，最低看至260美元
今日重点评级关注：Canaccord Genuity：维持Aurora Innovation"买入"评级，目标价从15美元升至17美元；摩根大通：维持皇家加勒比邮轮"超配"评级，目标价从345美元升至394美元
09-25 15:55
Goldman Sachs Reinstates Neutral on Kodiak Sciences, Announces $36 Price Target
Goldman Sachs analyst Andrea Newkirk reinstates Kodiak Sciences (NASDAQ:KOD) with a Neutral and announces $36 price target.
09-24 19:31
美股大行评级 | 潜在涨幅455.56%！Cardiol Therapeutics获Canaccord Genuity上调目标价至10美元，维持"买入"评级
今日重点评级关注：Canaccord Genuity：维持Cardiol Therapeutics"买入"评级，目标价从8美元升至10美元；B. Riley证券：维持Macrogenics"买入"评级，目标价从9美元升至11美元
08-18 11:39
3 Best Stocks With 75%+ Upside to Buy This Week, According to Analysts
Analysts see strong momentum in some stocksthis week, including Kodiak Sc...
08-18 05:20
Kodiak Sciences Q2 EPS $(1.05) Misses $(0.95) Estimate
Kodiak Sciences (NASDAQ:KOD) reported quarterly losses of $(1.05) per share which missed the analyst consensus estimate of $(0.95) by 10.53 percent. This is a 1.94 percent decrease over losses of $(1.03) per share from the same period last year.
08-14 04:03
